{
  "paper_id": "7fc0dd282134090033e84fcee70ee776aca7b6b0",
  "metadata": {
    "title": "Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia",
    "coda_data_split": "train",
    "coda_paper_id": 2794,
    "coda_has_expert_labels": false,
    "subset": "custom_license"
  },
  "abstract": [
    {
      "original_text": "We compared the clinical characteristics and antibiotic therapy of community-acquired pneumonia patients who were positive on a respiratory virus molecular test (polymerase chain reaction) with those who were negative. We found that respiratory virus molecular polymerase chain reaction testing has a minimal impact on reducing antibiotic utilization among viral pneumonia patients.",
      "sentences": [
        [
          {
            "segment_text": "We compared the clinical characteristics and antibiotic therapy of community-acquired pneumonia patients who were positive on a respiratory virus molecular test ( polymerase chain reaction ) with those who were negative .",
            "crowd_label": "method"
          }
        ],
        [
          {
            "segment_text": "We found that respiratory virus molecular polymerase chain reaction testing has a minimal impact on reducing antibiotic utilization among viral pneumonia patients .",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "1",
    "sentence_num": "2",
    "segment_num": "2",
    "token_num": "55"
  }
}